These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29353967)

  • 1. Methods for estimating complier average causal effects for cost-effectiveness analysis.
    DiazOrdaz K; Franchini AJ; Grieve R
    J R Stat Soc Ser A Stat Soc; 2018 Jan; 181(1):277-297. PubMed ID: 29353967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating treatment effects in randomised controlled trials with non-compliance: a simulation study.
    Ye C; Beyene J; Browne G; Thabane L
    BMJ Open; 2014 Jun; 4(6):e005362. PubMed ID: 24939814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating Causal Effects in Trials Involving Multi-Treatment Arms Subject to Non-compliance: A Bayesian framework.
    Long Q; Little RJ; Lin X
    J R Stat Soc Ser C Appl Stat; 2010 May; 59(3):513-531. PubMed ID: 21637737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing causal treatment effect estimation when using large observational datasets.
    John ER; Abrams KR; Brightling CE; Sheehan NA
    BMC Med Res Methodol; 2019 Nov; 19(1):207. PubMed ID: 31726969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrasting approaches for addressing non-adherence in randomized controlled trials: An illustration from the REFLUX trial.
    Keele L; Grieve R
    Clin Trials; 2022 Feb; 19(1):97-106. PubMed ID: 34949104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of treatment efficacy with complier average causal effects (CACE) in a randomized stepped wedge trial.
    Gruber JS; Arnold BF; Reygadas F; Hubbard AE; Colford JM
    Am J Epidemiol; 2014 May; 179(9):1134-42. PubMed ID: 24705812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simple Estimation of Patient-Oriented Effects From Randomized Trials: An Open and Shut CACE.
    Steele RJ; Shrier I; Kaufman JS; Platt RW
    Am J Epidemiol; 2015 Sep; 182(6):557-66. PubMed ID: 26283090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A causal model for longitudinal randomised trials with time-dependent non-compliance.
    Becque T; White IR; Haggard M
    Stat Med; 2015 May; 34(12):2019-34. PubMed ID: 25778798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A readily available improvement over method of moments for intra-cluster correlation estimation in the context of cluster randomized trials and fitting a GEE-type marginal model for binary outcomes.
    Westgate PM
    Clin Trials; 2019 Feb; 16(1):41-51. PubMed ID: 30295512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semiparametric transformation models for causal inference in time to event studies with all-or-nothing compliance.
    Yu W; Chen K; Sobel ME; Ying Z
    J R Stat Soc Series B Stat Methodol; 2015 Mar; 77(2):397-415. PubMed ID: 25870521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Causal inference methods to assess safety upper bounds in randomized trials with noncompliance.
    Wang Y; Berlin JA; Pinheiro J; Wilcox MA
    Clin Trials; 2015 Jun; 12(3):265-75. PubMed ID: 25733675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond intention to treat: what is the right question?
    Shrier I; Steele RJ; Verhagen E; Herbert R; Riddell CA; Kaufman JS
    Clin Trials; 2014 Feb; 11(1):28-37. PubMed ID: 24096636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local average treatment effects estimation via substantive model compatible multiple imputation.
    DiazOrdaz K; Carpenter J
    Biom J; 2019 Nov; 61(6):1526-1540. PubMed ID: 31456263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Instrumental variables and inverse probability weighting for causal inference from longitudinal observational studies.
    Hogan JW; Lancaster T
    Stat Methods Med Res; 2004 Feb; 13(1):17-48. PubMed ID: 14746439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A semiparametric instrumental variable approach to optimal treatment regimes under endogeneity.
    Cui Y; Tchetgen ET
    J Am Stat Assoc; 2021; 116(533):162-173. PubMed ID: 33994604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using audit information to adjust parameter estimates for data errors in clinical trials.
    Shepherd BE; Shaw PA; Dodd LE
    Clin Trials; 2012 Dec; 9(6):721-9. PubMed ID: 22848072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the sensitivity of methods for estimating principal causal effects.
    Stuart EA; Jo B
    Stat Methods Med Res; 2015 Dec; 24(6):657-74. PubMed ID: 21971481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model misspecification sensitivity analysis in estimating causal effects of interventions with non-compliance.
    Jo B
    Stat Med; 2002 Nov; 21(21):3161-81. PubMed ID: 12375297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient Centered Hazard Ratio Estimation Using Principal Stratification Weights: Application to the NORCCAP Randomized Trial of Colorectal Cancer Screening.
    MacKenzie TA; Løberg M; O'Malley AJ
    Obs Stud; 2016 Mar; 2():29-50. PubMed ID: 29644344
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.